// App-Quantinova.ai

11024 : Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal (GI) and genitourinary (GU) malignancies.

Researchers

Presenter

  • Tian Zhang

Principal Investigators

  • Rengasamy Boominathan

  • Brad Foulk

  • Mariano A. Garcia-Blanco

  • Gabor Kemeny

  • John H. Strickler

  • James L. Abbruzzese

  • Michael Roger Harrison

  • Daniel J. George

  • Herbert Hurwitz

  • Andrew J. Armstrong

  • Mark Carle Connelly

  • Chandra Rao

Medical Centers

  • Veridex LLC, Huntingdon Valley, PA

  • Duke University Medical Center, Durham, NCDuke Cancer Institute, Durham, NCDuke University, Durham, NC

  • Duke Cancer Institute, Durham, NC

  • Duke Cancer Institute, Duke University Medical Center, Durham, NC

  • Janssen Research and Development, LLC, Spring House, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Gastric Cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved